Captor Capital Releases Unaudited Condensed Interim Consolidated Financial Statements for Quarter Ended December 31, 2022

Stock Information for Entheon Biomedical Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Entheon Biomedical Corp.

Captor Capital Corp. Drives Strategic Expansion with US$500,000 Bitcoin Acquisition and US$450,000 Convertible Loan Note from European Institutional Investor
CSE Bulletin: Consolidation - Captor Capital Corp. (CPTR)
Captor Capital to Consolidate Common Shares
CSE Bulletin: Resumption - Captor Capital Corp. (CPTR)
Canadian Investment Regulatory Organization Trade Resumption - CPTR
Captor Capital Releases Audited Consolidated Financial Statements for Year Ended March 31, 2023
Captor Capital Announces Termination of RTO with Rimstock
Captor Capital Releases Unaudited Condensed Interim Consolidated Financial Statements for Quarter Ended September 30, 2022

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.